International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Ketamine 25-mg/mL Nasal Spray

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2004 - Endotoxin
View All Articles in Issue

Page(s): 475

Download in electronic PDF format for $75

Abstract: A formulation for preparing Ketamine 25-mg/mL Nasal Spray. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, pain control, pain relief

Related Categories: FORMULATIONS, PAIN MANAGEMENT

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Ketamine 25-mg/mL Nasal Spray Allen Loyd V Jr	Nov/Dec 2004 Pg. 475
Ketamine for Pain in Hospice Patients Wood Robert M	Jul/Aug 2000 Pg. 253-254
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L	May/Jun 2010 Pg. 200-203
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Rabi Joseph	Mar/Apr 2016 Pg. 107-113
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H	Mar/Apr 2018 Pg. 172-175
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle	Nov/Dec 2016 Pg. 517-520
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jul/Aug 2015 Pg. 295-300
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen Zugerman Jessie Jean M, Reed Thomas C	Nov/Dec 2007 Pg. 514-519
Butorphanol Tartrate 10-mg/mL Nasal Spray Allen Loyd V Jr	May/Jun 2014 Pg. 235
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report McNulty Jack P, Hahn Kristian	Sep/Oct 2012 Pg. 364-368
Case Reports: Compounding to Relieve Arthritis Pain Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane	Nov/Dec 2008 Pg. 498-504
Update on Managing Neuropathic Pain McNulty Jack P, Muller George	May/Jun 2009 Pg. 182-190
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray Allen Loyd V Jr	Mar/Apr 2016 Pg. 147
Pain: Systematic Review of Pharmacy Compounding of Pain Medication Shawaqfeh Mohammad S, Harrington Catherine	Jan/Feb 2018 Pg. 19-24
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications Warner Meredith, Tuder Dmitry	May/Jun 2014 Pg. 182-188
Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection Allen Loyd V Jr	May/Jun 2004 Pg. 220
Return to Top